Four Cases of Cholesterol Management Informed by the 2018 American Heart Association/American College of Cardiology Multisociety Guideline on the Management of Blood Cholesterol

Sarah Chuzi; Anna Pfenniger; Donald M. Lloyd-Jones; Roger S. Blumenthal; Sidney C. Smith; Salim S. Virani; Scott M. Grundy; Neil J. Stone

doi:10.1001/jamacardio.2019.0771

Four Cases of Cholesterol Management Informed by the 2018 American Heart Association/American College of Cardiology Multisociety Guideline on the Management of Blood Cholesterol

Sarah Chuzi, Anna Pfenniger, Donald M. Lloyd-Jones, Roger S. Blumenthal, Sidney C. Smith, Salim S. Virani, Scott M. Grundy, Neil J. Stone^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

These 4 hypothetical cases highlight some of the new features in the 2018 American Heart Association/American College of Cardiology multisociety cholesterol management guidelines. Topics include management issues in a secondary prevention patient judged to be at very high risk of another event, a patient with familial hypercholesterolemia with a low-density lipoprotein cholesterol level of 190 mg/dL or greater (to convert to millimoles per liter, multiply by 0.0259), a primary prevention patient with intermediate (7.5%-19.9%) 10-year atherosclerotic cardiovascular risk, and a patient who has statin-associated adverse effects. A multiple-choice format is used to engage clinicians in selecting the best choice based on guidance from the new 2018 cholesterol management guidelines..

Original language	English (US)
Pages (from-to)	473-477
Number of pages	5
Journal	JAMA cardiology
Volume	4
Issue number	5
DOIs	https://doi.org/10.1001/jamacardio.2019.0771
State	Published - May 2019

Funding

received grants from the US Department of Veterans Affairs, American Heart Association, American Diabetes Association, and Baylor Global Initiative and honorarium from the American

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1001/jamacardio.2019.0771

Cite this

Chuzi, S., Pfenniger, A., Lloyd-Jones, D. M., Blumenthal, R. S., Smith, S. C., Virani, S. S., Grundy, S. M., & Stone, N. J. (2019). Four Cases of Cholesterol Management Informed by the 2018 American Heart Association/American College of Cardiology Multisociety Guideline on the Management of Blood Cholesterol. JAMA cardiology, 4(5), 473-477. https://doi.org/10.1001/jamacardio.2019.0771

@article{e1c88da94d454e56bcdb9f34a796ee36,

title = "Four Cases of Cholesterol Management Informed by the 2018 American Heart Association/American College of Cardiology Multisociety Guideline on the Management of Blood Cholesterol",

abstract = "These 4 hypothetical cases highlight some of the new features in the 2018 American Heart Association/American College of Cardiology multisociety cholesterol management guidelines. Topics include management issues in a secondary prevention patient judged to be at very high risk of another event, a patient with familial hypercholesterolemia with a low-density lipoprotein cholesterol level of 190 mg/dL or greater (to convert to millimoles per liter, multiply by 0.0259), a primary prevention patient with intermediate (7.5%-19.9%) 10-year atherosclerotic cardiovascular risk, and a patient who has statin-associated adverse effects. A multiple-choice format is used to engage clinicians in selecting the best choice based on guidance from the new 2018 cholesterol management guidelines..",

author = "Sarah Chuzi and Anna Pfenniger and Lloyd-Jones, {Donald M.} and Blumenthal, {Roger S.} and Smith, {Sidney C.} and Virani, {Salim S.} and Grundy, {Scott M.} and Stone, {Neil J.}",

year = "2019",

month = may,

doi = "10.1001/jamacardio.2019.0771",

language = "English (US)",

volume = "4",

pages = "473--477",

journal = "JAMA cardiology",

issn = "2380-6583",

publisher = "American Medical Association",

number = "5",

}

Chuzi, S , Pfenniger, A , Lloyd-Jones, DM, Blumenthal, RS, Smith, SC, Virani, SS, Grundy, SM & Stone, NJ 2019, 'Four Cases of Cholesterol Management Informed by the 2018 American Heart Association/American College of Cardiology Multisociety Guideline on the Management of Blood Cholesterol', JAMA cardiology, vol. 4, no. 5, pp. 473-477. https://doi.org/10.1001/jamacardio.2019.0771

TY - JOUR

T1 - Four Cases of Cholesterol Management Informed by the 2018 American Heart Association/American College of Cardiology Multisociety Guideline on the Management of Blood Cholesterol

AU - Chuzi, Sarah

AU - Pfenniger, Anna

AU - Lloyd-Jones, Donald M.

AU - Blumenthal, Roger S.

AU - Smith, Sidney C.

AU - Virani, Salim S.

AU - Grundy, Scott M.

AU - Stone, Neil J.

PY - 2019/5

Y1 - 2019/5

N2 - These 4 hypothetical cases highlight some of the new features in the 2018 American Heart Association/American College of Cardiology multisociety cholesterol management guidelines. Topics include management issues in a secondary prevention patient judged to be at very high risk of another event, a patient with familial hypercholesterolemia with a low-density lipoprotein cholesterol level of 190 mg/dL or greater (to convert to millimoles per liter, multiply by 0.0259), a primary prevention patient with intermediate (7.5%-19.9%) 10-year atherosclerotic cardiovascular risk, and a patient who has statin-associated adverse effects. A multiple-choice format is used to engage clinicians in selecting the best choice based on guidance from the new 2018 cholesterol management guidelines..

AB - These 4 hypothetical cases highlight some of the new features in the 2018 American Heart Association/American College of Cardiology multisociety cholesterol management guidelines. Topics include management issues in a secondary prevention patient judged to be at very high risk of another event, a patient with familial hypercholesterolemia with a low-density lipoprotein cholesterol level of 190 mg/dL or greater (to convert to millimoles per liter, multiply by 0.0259), a primary prevention patient with intermediate (7.5%-19.9%) 10-year atherosclerotic cardiovascular risk, and a patient who has statin-associated adverse effects. A multiple-choice format is used to engage clinicians in selecting the best choice based on guidance from the new 2018 cholesterol management guidelines..

UR - http://www.scopus.com/inward/record.url?scp=85064349253&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064349253&partnerID=8YFLogxK

U2 - 10.1001/jamacardio.2019.0771

DO - 10.1001/jamacardio.2019.0771

M3 - Article

C2 - 30969319

AN - SCOPUS:85064349253

SN - 2380-6583

VL - 4

SP - 473

EP - 477

JO - JAMA cardiology

JF - JAMA cardiology

IS - 5

ER -

Four Cases of Cholesterol Management Informed by the 2018 American Heart Association/American College of Cardiology Multisociety Guideline on the Management of Blood Cholesterol

Abstract

Funding

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this